technetium tc 99m etidronate has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alshehri, AHD; Campfield, C; Cole, AJ; Jain, SFP; O'Sullivan, JM; Osman, SOS; Prise, KM; Turner, PG | 1 |
1 other study(ies) available for technetium tc 99m etidronate and Prostatic Neoplasms, Castration-Resistant
Article | Year |
---|---|
A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organotechnetium Compounds; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Regression Analysis; Software Design; Tumor Burden; Urinary Bladder | 2020 |